πŸ‡ΊπŸ‡Έ FDA
Patent

US 10689400

Macrocycle kinase inhibitors

granted A61KA61K45/06A61P

Quick answer

US patent 10689400 (Macrocycle kinase inhibitors) held by TURNING POINT THERAPEUTICS, INC. expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TURNING POINT THERAPEUTICS, INC.
Grant date
Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K45/06, A61P, A61P19/02, A61P25/00